The authorization offers the U.S. three COVID-19 vaccines for distribution and its first single-shot vaccine.
WASHINGTON — The U.S. is getting a 3rd vaccine to stop COVID-19, because the Meals and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with only one dose as a substitute of two.
Well being consultants are anxiously awaiting a one-and-done choice to assist velocity vaccinations, as they race towards a virus that already has killed greater than 510,000 individuals within the U.S. and is mutating in more and more worrisome methods.
The FDA stated J&J’s vaccine presents sturdy safety towards what issues most: critical sickness, hospitalizations and demise. One dose was 85% protecting towards probably the most extreme COVID-19 sickness, in a large examine that spanned three continents — safety that remained sturdy even in nations comparable to South Africa, the place the variants of most concern are spreading.
RELATED: Fauci: No matter COVID vaccine is offered, take it
RELATED: Evaluating Pfizer, Moderna and J&J photographs is not an apples-to-apples comparability
“The extra vaccines which have excessive efficacy that we are able to get into play, the higher,” Dr. Anthony Fauci, the highest U.S. infectious illness professional, stated forward of the FDA’s ruling.
Shipments of some million doses to be divided amongst states might start as early as Monday. By the tip of March, J&J has stated it expects to ship 20 million doses to the U.S., and 100 million by summer season.
J&J is also searching for authorization for emergency use of its vaccine in Europe and from the World Well being Group. Worldwide, the corporate goals to provide about 1 billion doses globally by the tip of the yr. On Thursday, the island nation of Bahrain grew to become the primary to clear its use.
The Related Press Well being and Science Division receives help from the Howard Hughes Medical Institute’s Division of Science Schooling. The AP is solely liable for all content material.